(8-096) CLX-155A: Preclinical Evaluation of a Novel Oral 5-FU and Valproic Acid Prodrug for Triple-Negative Breast Cancer in a Nude Mouse Xenograft Model
Tuesday, December 9, 2025
2:00 PM - 3:30 PM
Location: Bayside A, Level 1
Fellowship Program: Rutgers Pharmaceutical Industry Fellowship Program Fellowship Location: New Jersey
Co-Author(s): Michika Maeda, Subbu Apparsundaram, John York
